An arena to get inspired and connect
As a global hub for science and technology, the Swedish city of Uppsala is the ideal location for a forum on AMR research. Home to two universities, medical & veterinary research institutions, as well as several big players from the industry, Uppsala provides the ideal environment for creativity and innovation. We are pleased to announce the hosting of the third Uppsala Antibiotic Days in June, 2026, a now-established space to contribute to the dialogue around AMR. The conference aims to bring together researchers, clinicians, students, and the community at large to present their breakthroughs and experiences with AMR.
Our 2024 edition featured keynote talks, short talks from selected submitted abstracts, a poster session, and more!
We will be updating the page with information about the 2026 as new details become available, meanwhile you can explore what the 2024 edition brought us!
Conference topics
Is this conference for you? Organized by thematic sessions,
the Uppsala Antibiotic Days 2026 will host talks on an array of AMR topics:
Drug discovery & Economics
After the golden era of antibiotics, we have been facing a dry pipeline for decades. Here we examined what is the current situation of the discovery of new antimicrobial drugs and the aspects of financing and economics in this area.
Social Sciences & Education
With behaviour and human action as key aspects of AMR, we talked in this session about how research on social sciences and education are part of the solution.
Diagnostics & Infection Control
Effective management of infectious diseases depends on both rapid diagnostics and strong infection control practices. This session highlights new research, tools, and strategies that improve detection, prevention, and IPC across settings.
Vaccines & Complements to Antibiotics
New approaches are reshaping how we prevent and treat bacterial infections. This session focuses on vaccines and other therapeutic options that work alongside or instead of antibiotics to enhance treatment outcomes and slow resistance development.
Collateral Effects of Antibiotics
Antibiotics save lives but also affect the microbiome, the environment, and resistance dynamics. This session examines the broader consequences of antibiotic use and explores strategies to reduce unwanted impacts on health and ecosystems.
Emerging AMR Pathogens
New resistant pathogens are emerging, including new bacterial species, viruses, fungi, and parasites. Here we explored resistance with an outlook to the future.
Keynote Speakers
Take a look at the confirmed keynote speakers for our upcoming 2026 conference
Ursula Theuretzbacher
Founder of the Center for Anti-Infective Agents (CEFAIA) & independent expert in antibacterial drug discovery and development strategies.
Rafael Cantón
Head of the Clinical Microbiology Department at the Ramón y Cajal University Hospital in Madrid (Spain) and Associate Professor of Clinical Microbiology at Complutense University in Madrid.
Anne Kvem Lie
Professor at the University of Oslo’s Department of Community Medicine and Global Health, specializing in the history of medicine.
Rob Warren
Distinguished Professor at Stellenbosch University (SU) and heads the TB Genomics research group in the Division of Molecular Biology and Human Genetics in the Faculty of Medicine and Health Sciences.
Rena Conti
Associate Professor of Markets, Public Policy, and Law at Boston University’s Questrom School of Business. She co-directs the Technology Policy and Research Initiative and leads work on biopharmaceutical markets at the Ravi K. Mehrotra Institute for Business, Markets, and Society.
Joakim Larsson
Professor of Environmental Pharmacology at the University of Gothenburg’s Department of Infectious Diseases, and director of the Centre for Antibiotic Resistance Research (CARe).
Evelina Taconelli
Full Professor of Infectious Diseases and Director of the Infectious Diseases Division at the University of Verona, Italy. She serves as Chief Scientific Officer of the European Clinical Research Alliance on Infectious Diseases (ECRAID).
Scott Weese
Veterinary internist and Professor at the Ontario Veterinary College, University of Guelph, Director of the University of Guelph Centre for Public Health and Zoonoses, Chief of Infection Control at the Ontario Veterinary College Health Sciences Centre.
Martha Clokie
Professor of Microbiology at the University of Leicester and Director of the Becky Mayer Centre for Phage Research.
